Showing results (91-100 of 927) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|July 25, 2020
Associations between androgens and sexual function in premenopausal women: a cross-sectional studyJia Zheng, Rakibul M Islam, Marina A Skiba, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2020
Endocrine-disrupting chemicals: implications for human healthLinda G Kahn, Claire Philippat, Shoji F Nakayama, et al.
The Lancet. Diabetes & Endocrinology|March 11, 2015
Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trialWeiping Jia, Xinhua Xiao, Qiuhe Ji, et al.
The Lancet. Diabetes & Endocrinology|March 11, 2015
Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling studySung-Ching Pan, Chu-Chang Ku, Diana Kao, et al.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trialJohn Furler, David O'Neal, Jane Speight, et al.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participantsNelson Wang, Jordan Fulcher, Nishan Abeysuriya, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2020
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trialNete Tofte, Morten Lindhardt, Katarina Adamova, et al.
The Lancet. Diabetes & Endocrinology|March 2, 2020
Screening for diabetic retinopathy: new perspectives and challengesStela Vujosevic, Stephen J Aldington, Paolo Silva, et al.
The Lancet. Diabetes & Endocrinology|January 15, 2019
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trialMichael P Whyte, Thomas O Carpenter, Gary S Gottesman, et al.
The Lancet. Diabetes & Endocrinology|February 2, 2019
The obesity transition: stages of the global epidemicLindsay M Jaacks, Stefanie Vandevijvere, An Pan, et al.
Pageof 93